China Southern Fund Management Co., Ltd. - Hang Seng Hk Listed Biotech ETF (SHE:159615)

China · Delayed Price · Currency is CNY

1.192

-0.004 (-0.33%)

At close: Sep 23, 2026

Assets	387.95M
Expense Ratio	0.65%
PE Ratio	17.64
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-13.18%

Volume	104,512,500
Open	1.199
Previous Close	1.196
Day's Range	1.190 - 1.213
52-Week Low	0.858
52-Week High	1.417
Beta	0.73
Holdings	n/a
Inception Date	Jun 17, 2022

About 159615

159615.SZ was created on 2022-06-17 by China Southern. The fund's investment portfolio concentrates primarily on health care equity. Closely track underlying index,Tightly track the target and minimize the deviation

Asset Class Equity

Category Health Care

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 159615

Provider China Southern

Index Tracked Hang Seng Biotech Index - HKD - Benchmark TR Gross

Performance

159615 had a total return of -13.18% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.43%.